Combining EpCAM with cell-surface vimentin (CSV) in circulating tumor cell enrichment could also be a promising strategy to enhance the capture of heterogeneous CTC populations, while addressing the limitations of relying solely on EpCAM-based methods [101,102,103,104,105]. The gene discussed is VIM; the disease is neoplasm.